The overall aim of the project is to establish an international multi-cohort research platform of HIV/HBV-coinfected individuals treated with tenofovir to improve our understanding of the determinants of treatment outcomes.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
HBV suppression
Timeframe: 2 years of TDF/TAF-containing treatment and last available timepoint
HBsAg loss
Timeframe: 2 years of TDF/TAF-containing treatment and last available timepoint
HBeAg loss
Timeframe: 2 years of TDF/TAF-containing treatment and last available timepoint
Transaminase normalization
Timeframe: 2 years of TDF/TAF-containing treatment and last available timepoint
Liver fibrosis change
Timeframe: 2 years of TDF/TAF-containing treatment and last available timepoint
Treatment interruption or change
Timeframe: 2 years of TDF/TAF-containing treatment and last available timepoint